Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Agents and Actions
|
July 1, 1991
Granulocyte chemotaxis in the canine trachea: inhibition by lipid mediator antagonists and systemic inhibitors
H G Johnson, M L McNee
International Archives of Allergy and Applied Immunology
|
January 1, 1984
Regulation of canine mucus secretion by a novel leukotriene synthesis inhibitor (U-60,257)
H G Johnson, M L McNee
Prostaglandins
|
February 1, 1985
Airway responses to aerosolized leukotriene D4 (LTD4) in normal and Ascaris reactor primates
H G Johnson, B K Stout
British Journal of Pharmacology
|
September 1, 1985
Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives
H G Johnson, M L McNee
The American Review of Respiratory Disease
|
March 1, 1989
Ascaris suum ova-induced bronchoconstriction, eosinophilia, and IgE antibody responses in experimentally infected primates did not lead to histamine hyperreactivity
H G Johnson, B K Stout
Monographs in Allergy
|
January 1, 1979
Development of new antiallergic drugs (cromolyn sodium, lodoxamide tromethamine). What is the role of cholinergic stimulation in the biphasic dose response?
H G Johnson, G J White
The Journal of Experimental Medicine
|
March 1, 1971
Regulation of the immune system by synthetic polynucleotides. II. Action on peritoneal exudate cells
H G Johnson, A G Johnson
Journal of Medicinal Chemistry
|
January 1, 1977
(2-Carboxy-1,4-dihydro-4-oxoquinolyl)oxamic acids and (2-carboxy-1,4-dihydro-4-oxobenzo[h]quinolyl)oxamic acids as antiallergy agents
J B Wright, H G Johnson
Agents and Actions
|
June 1, 1986
The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma
H G Johnson, A Q Sheridan
International Archives of Allergy and Immunology
|
January 1, 1993
Late phase bronchoconstriction and eosinophilia as well as methacholine hyperresponsiveness in Ascaris-sensitive rhesus monkeys were reversed by oral administration of U-83836E
H G Johnson, B K Stout
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Agents and Actions
|
July 1, 1991
Granulocyte chemotaxis in the canine trachea: inhibition by lipid mediator antagonists and systemic inhibitors
H G Johnson, M L McNee
International Archives of Allergy and Applied Immunology
|
January 1, 1984
Regulation of canine mucus secretion by a novel leukotriene synthesis inhibitor (U-60,257)
H G Johnson, M L McNee
Prostaglandins
|
February 1, 1985
Airway responses to aerosolized leukotriene D4 (LTD4) in normal and Ascaris reactor primates
H G Johnson, B K Stout
British Journal of Pharmacology
|
September 1, 1985
Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives
H G Johnson, M L McNee
The American Review of Respiratory Disease
|
March 1, 1989
Ascaris suum ova-induced bronchoconstriction, eosinophilia, and IgE antibody responses in experimentally infected primates did not lead to histamine hyperreactivity
H G Johnson, B K Stout
Monographs in Allergy
|
January 1, 1979
Development of new antiallergic drugs (cromolyn sodium, lodoxamide tromethamine). What is the role of cholinergic stimulation in the biphasic dose response?
H G Johnson, G J White
The Journal of Experimental Medicine
|
March 1, 1971
Regulation of the immune system by synthetic polynucleotides. II. Action on peritoneal exudate cells
H G Johnson, A G Johnson
Journal of Medicinal Chemistry
|
January 1, 1977
(2-Carboxy-1,4-dihydro-4-oxoquinolyl)oxamic acids and (2-carboxy-1,4-dihydro-4-oxobenzo[h]quinolyl)oxamic acids as antiallergy agents
J B Wright, H G Johnson
Agents and Actions
|
June 1, 1986
The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma
H G Johnson, A Q Sheridan
International Archives of Allergy and Immunology
|
January 1, 1993
Late phase bronchoconstriction and eosinophilia as well as methacholine hyperresponsiveness in Ascaris-sensitive rhesus monkeys were reversed by oral administration of U-83836E
H G Johnson, B K Stout
Page
of 5